| Serial Number | 79402612 |
| Word Mark | CARSGEN |
| Filing Date | Tuesday, April 9, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Friday, April 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases ; drugs for medical purposes, namely, pharmaceutical preparations for treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biological preparations for medical purposes for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; medicinal solutions for injection, namely, medicines for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biomedicine for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; blood for medical purposes; pre-filled syringes for medical purposes filled with pharmaceutical preparations for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biological tissue cultures for medical purposes; serotherapeutic medicines for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases |
| Goods and Services | Medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; human tissue bank services; alternative medicine services; therapy services, namely, medical therapy, medicine therapy, immunotherapy, cell therapy, gene therapy, antibody therapy, antibody-drug conjugate therapy, radiation therapy, chemotherapy, or stem cell therapy; telemedicine services; health care; medical clinic services |
| Goods and Services | Scientific research; scientific laboratory services; research and development of new products for others; technical project studies, namely, conducting scientific feasibility studies; technological research in the field of pharmaceutical studies, biotechnology, medicine, immunotherapy; chemical research; chemistry services, namely, chemist services and chemistry consultation; chemical analysis; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 22, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 22, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CARsgen Therapeutics Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, August 22, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, August 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 22, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 29, 2024 | REFUSAL PROCESSED BY MPU |
| Tuesday, October 22, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 23, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, October 29, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, April 1, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 1, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 1, 2025 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, April 1, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, April 1, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 1, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sunday, November 17, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, April 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 4, 2025 | FINAL REFUSAL WRITTEN |
| Friday, April 4, 2025 | FINAL REFUSAL E-MAILED |
| Friday, April 4, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, April 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |